OBJECTIVES: To define normal values of the beginning and duration of the hepatic arterial phase (HAP) during contrast-enhanced computed tomography (CT). METHODS: Twenty-five volunteers (16 men, 9 women; mean age, 60.0 years) without history or suspicion of liver disease were examined with dynamic single-section CT. Scanning was performed at a single level that included the liver, aorta, and portal vein. A series of 25 scans was obtained over a period of 88 seconds (1 baseline scan followed by 16 scans every 2 seconds and 8 scans every 7 seconds) beginning with the injection of a bolus of contrast agent (40 mL, 10 mL/s) and a 40-mL NaCl bolus chaser. Contrast enhancement in the liver, aorta, and portal vein was measured with regions of interest, and time-density curves were obtained. These data were processed with a pharmacodynamic fitting program and the duration of the HAP was calculated. The onsets of the HAP and the portal venous phase were assessed as lag times, referring to the beginning of enhancement in the abdominal aorta. RESULTS: The mean lag time of the HAP was 5.4 seconds after the aorta and the mean duration was 8.6 seconds. The mean lag time of the portal venous phase was 13.9 seconds after the aorta. CONCLUSIONS: These data can be used to optimize protocols for routine CT. Because of the short duration of the HAP, imaging of the entire liver during this phase is possible only with multidetector CT scanners.
OBJECTIVES: To define normal values of the beginning and duration of the hepatic arterial phase (HAP) during contrast-enhanced computed tomography (CT). METHODS: Twenty-five volunteers (16 men, 9 women; mean age, 60.0 years) without history or suspicion of liver disease were examined with dynamic single-section CT. Scanning was performed at a single level that included the liver, aorta, and portal vein. A series of 25 scans was obtained over a period of 88 seconds (1 baseline scan followed by 16 scans every 2 seconds and 8 scans every 7 seconds) beginning with the injection of a bolus of contrast agent (40 mL, 10 mL/s) and a 40-mL NaCl bolus chaser. Contrast enhancement in the liver, aorta, and portal vein was measured with regions of interest, and time-density curves were obtained. These data were processed with a pharmacodynamic fitting program and the duration of the HAP was calculated. The onsets of the HAP and the portal venous phase were assessed as lag times, referring to the beginning of enhancement in the abdominal aorta. RESULTS: The mean lag time of the HAP was 5.4 seconds after the aorta and the mean duration was 8.6 seconds. The mean lag time of the portal venous phase was 13.9 seconds after the aorta. CONCLUSIONS: These data can be used to optimize protocols for routine CT. Because of the short duration of the HAP, imaging of the entire liver during this phase is possible only with multidetector CT scanners.
Authors: Filippo Cademartiri; Nico Mollet; Aad van der Lugt; Koen Nieman; Peter M T Pattynama; Pim J de Feyter; Gabriel P Krestin Journal: Eur Radiol Date: 2003-12-19 Impact factor: 5.315
Authors: Philip M Lee; Hsin-Yu Chen; Jeremy W Gordon; Zhen J Wang; Robert Bok; Ralph Hashoian; Yaewon Kim; Xiaoxi Liu; Tanner Nickles; Kiersten Cheung; Francesca De Las Alas; Heather Daniel; Peder E Z Larson; Cornelius von Morze; Daniel B Vigneron; Michael A Ohliger Journal: J Magn Reson Imaging Date: 2022-04-14 Impact factor: 5.119